Crisaborole: A Novel Topical Non-Steroidal Anti-Inflammatory for Atopic Dermatitis Treatment

Discover the benefits of Crisaborole, a potent PDE4 inhibitor for effective eczema and atopic dermatitis management.

Get a Quote & Sample

Key Advantages

Targeted Inflammation Control

By specifically inhibiting PDE4, Crisaborole effectively reduces the production of inflammatory cytokines, offering targeted relief for skin conditions.

Non-Steroidal Alternative

As a non-steroidal option, Crisaborole provides a safer alternative to corticosteroids, minimizing the risk of long-term side effects associated with steroid use.

Research and Development Support

High-purity Crisaborole serves as a critical pharmaceutical reference standard, vital for analytical method development and validation in drug research.

Key Applications

Atopic Dermatitis Treatment

Crisaborole is a well-established treatment for mild-to-moderate atopic dermatitis, offering relief from itching and inflammation.

Eczema Therapy

Its anti-inflammatory properties make it an effective option for managing various forms of eczema and associated skin discomfort.

Dermatology Research

Used extensively in dermatology research, Crisaborole aids in understanding inflammatory skin conditions and developing new therapeutic strategies.

Pharmaceutical Standards

As a high-quality chemical compound, it is crucial for pharmaceutical companies needing reliable reference standards for quality control and R&D.